Ichthammol ointment 10 %

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT ICHTHYOL OINTMENT 10%

Composition:

Active ingredient: ichthammol;

1 g of ointment contains 100 mg of ichthammol;

Excipient: white soft paraffin.

Pharmaceutical form. Ointment.

Main physicochemical characteristics: dark brown ointment with the odor of ichthammol. The ointment should be homogeneous in appearance.

Pharmacotherapeutic group.

Antiseptics and disinfectants.

ATC Code D08AX.

Pharmacological properties.

Pharmacodynamics. The pharmacological properties of ichthammol ointment are determined by the action of biologically active substances of ichthammol. Ichthammol ointment has antimicrobial (bactericidal and bacteriostatic), anti-inflammatory, and local analgesic effects.

Pharmacokinetics. When applied topically, ichthammol ointment is practically not absorbed into the systemic circulation and does not exhibit resorptive effects.

Clinical characteristics.

Indications.

Burns, eczema, erysipelas, neuralgia, arthritis.

Contraindications.

Hypersensitivity to the components of the drug.

Special safety precautions.

Avoid contact of the ointment with mucous membranes.

Hands should be thoroughly washed after applying the ointment to prevent residual ointment from entering the eyes, nose, or mouth.

Interaction with other medicinal products and other forms of interaction.

When used simultaneously with topical preparations, new compounds with unpredictable effects may form. Incompatible with solutions of iodides, alkaloids, and heavy metal salts.

Special precautions.

Use during pregnancy or breastfeeding.

Breastfeeding women should avoid contact of the ointment with the nipples. Safety and efficacy of the medicinal product during pregnancy or breastfeeding have not been studied.

Effect on the ability to drive or operate machinery.

The effect of the medicinal product on the ability to drive or operate machinery has not been described.

Dosage and Administration.

For external use only. Apply a thin layer of the ointment to the affected areas of skin 2–3 times daily and cover with a dressing. The duration of treatment is determined by the course of the disease and the therapeutic response.

Used as part of combination therapy for the treatment of decubitus ulcers, complicated forms of burns, arthritis, neuralgia, and eczema.

The patient should consult a physician if symptoms persist during treatment or if adverse reactions not listed in the instructions for medical use occur.

Children.

Experience with use in children has not been described.

Overdose.

No cases of overdose have been reported.

Side effects.

Allergic reactions and skin irritation (burning, itching, rash, redness of the skin) are possible, especially at the beginning of treatment and during prolonged use. If severe skin irritation or other unusual reactions occur, application of the ointment should be discontinued.

Shelf life. 5 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging. 30 g in tubes.

Availability category. Over-the-counter.

Manufacturer. JSC "FITOFARM".

Manufacturer's address and location of business activity.

2 Sybirtseva St., Bakhmut, Donetsk region, 84500, Ukraine.

Marketing Authorization Holder. JSC "FITOFARM".

Address of the Marketing Authorization Holder.

7, Verkhovnoi Rady Blvd., premises 18, 3rd floor, Kyiv, 02100, Ukraine.